接受利妥昔单抗治疗的患者中与spiel螺旋体相关的神经螺旋体病

IF 7.2 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2025-01-16 DOI:10.3201/eid3102.240777

Timothée Carette, Louisien Lebrun, Benoît Kabamba-Mukadi, Jean-Marc Raymackers, Jean-Louis Bayart

{"title":"接受利妥昔单抗治疗的患者中与spiel螺旋体相关的神经螺旋体病","authors":"Timothée Carette, Louisien Lebrun, Benoît Kabamba-Mukadi, Jean-Marc Raymackers, Jean-Louis Bayart","doi":"10.3201/eid3102.240777","DOIUrl":null,"url":null,"abstract":"A 58-year-old woman in Belgium with a history of follicular lymphoma treated with rituximab sought care for a rapid sensory-motor deficit. Seronegative neuroborreliosis caused by Borrelia spielmanii was diagnosed, likely related to humoral deficiency. High CXC motif chemokine ligand 13 levels and PCR confirmed the diagnosis. Ceftriaxone treatment led to full recovery.","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"6 1","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Borrelia spielmanii–Associated Neuroborreliosis in Patient Receiving Rituximab, Belgium\",\"authors\":\"Timothée Carette, Louisien Lebrun, Benoît Kabamba-Mukadi, Jean-Marc Raymackers, Jean-Louis Bayart\",\"doi\":\"10.3201/eid3102.240777\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 58-year-old woman in Belgium with a history of follicular lymphoma treated with rituximab sought care for a rapid sensory-motor deficit. Seronegative neuroborreliosis caused by Borrelia spielmanii was diagnosed, likely related to humoral deficiency. High CXC motif chemokine ligand 13 levels and PCR confirmed the diagnosis. Ceftriaxone treatment led to full recovery.\",\"PeriodicalId\":11595,\"journal\":{\"name\":\"Emerging Infectious Diseases\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":7.2000,\"publicationDate\":\"2025-01-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emerging Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3201/eid3102.240777\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3102.240777","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

比利时一名58岁妇女，有滤泡性淋巴瘤史，接受利妥昔单抗治疗，因快速感觉运动缺陷寻求护理。诊断为由spielmanborrelia引起的血清阴性神经疏螺旋体病，可能与体液缺乏有关。高CXC基序趋化因子配体13水平和PCR证实了诊断。头孢曲松治疗使患者完全康复。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Borrelia spielmanii–Associated Neuroborreliosis in Patient Receiving Rituximab, Belgium

A 58-year-old woman in Belgium with a history of follicular lymphoma treated with rituximab sought care for a rapid sensory-motor deficit. Seronegative neuroborreliosis caused by Borrelia spielmanii was diagnosed, likely related to humoral deficiency. High CXC motif chemokine ligand 13 levels and PCR confirmed the diagnosis. Ceftriaxone treatment led to full recovery.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.